571 related articles for article (PubMed ID: 8055451)
1. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
Ohuchi N; Furuta A; Mori S
Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ-associated nipple discharge: a clinical marker for locally extensive disease.
Bauer RL; Eckhert KH; Nemoto T
Ann Surg Oncol; 1998; 5(5):452-5. PubMed ID: 9718176
[TBL] [Abstract][Full Text] [Related]
3. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.
Brachtel EF; Rusby JE; Michaelson JS; Chen LL; Muzikansky A; Smith BL; Koerner FC
J Clin Oncol; 2009 Oct; 27(30):4948-54. PubMed ID: 19720921
[TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ of the male breast.
Camus MG; Joshi MG; Mackarem G; Lee AK; Rossi RL; Munson JL; Buyske J; Barbarisi LJ; Sanders LE; Hughes KS
Cancer; 1994 Aug; 74(4):1289-93. PubMed ID: 8055450
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
6. Duct carcinoma in situ: biological implications for clinical practice.
Lagios MD
Semin Oncol; 1996 Feb; 23(1 Suppl 2):6-11. PubMed ID: 8614847
[TBL] [Abstract][Full Text] [Related]
7. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
[TBL] [Abstract][Full Text] [Related]
8. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
[TBL] [Abstract][Full Text] [Related]
9. Utility of four-quadrant random sections in mastectomy specimens.
Gupta D; Nath M; Layfield LJ
Breast J; 2003; 9(4):307-11. PubMed ID: 12846866
[TBL] [Abstract][Full Text] [Related]
10. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
[TBL] [Abstract][Full Text] [Related]
11. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
[TBL] [Abstract][Full Text] [Related]
14. [Intraductal spread of carcinoma: a risk for breast conserving surgery].
Ohuchi N; Furuta A; Mori S
Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():183-9. PubMed ID: 8037480
[TBL] [Abstract][Full Text] [Related]
15. A look into the ductoscope: its role in pathologic nipple discharge.
Fisher CS; Margenthaler JA
Ann Surg Oncol; 2011 Oct; 18(11):3187-91. PubMed ID: 21861230
[TBL] [Abstract][Full Text] [Related]
16. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy.
Goldstein NS; Kestin L; Vicini F
Am J Surg Pathol; 1999 Nov; 23(11):1340-8. PubMed ID: 10555002
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of growth pattern and extension of tumor-associated intraductal carcinoma of the breast.
Eggemann H; Kalinski T; Ruhland AK; Ignatov T; Costa SD; Ignatov A
Clin Breast Cancer; 2015 Jun; 15(3):227-33. PubMed ID: 25516401
[TBL] [Abstract][Full Text] [Related]
18. Pathological assessment of intraductal spread of carcinoma in relation to surgical margin state in breast-conserving surgery.
Ishida T; Furuta A; Moriya T; Ohuchi N
Jpn J Clin Oncol; 2003 Apr; 33(4):161-6. PubMed ID: 12810829
[TBL] [Abstract][Full Text] [Related]
19. [In situ ductal carcinoma of the breast].
Peña-Estévez VL; Aguilar U; Torrescano Granillo A
Ginecol Obstet Mex; 1999 Feb; 67():43-9. PubMed ID: 10327763
[TBL] [Abstract][Full Text] [Related]
20. Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ.
Ekatah GE; Turnbull AK; Arthur LM; Thomas J; Dodds C; Dixon JM
Eur J Surg Oncol; 2017 Nov; 43(11):2029-2035. PubMed ID: 28917445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
